Hypoactive Sexual Desire Disorder

Hypoactive sexual desire disorder (HSDD), now known as female sexual interest/arousal disorder, is a sexual dysfunction that causes a lowered sex drive in women. Many women will pass off the symptoms of HSDD as the inevitable effects of aging or changes in their body.

 

Cluster Number:
Wiki Number: W099
Diagnosis: Hypoactive Sexual Desire Disorder
US Patients: 10%Women
World Patients:
Sex Ratio:
Age Onset:
Brain Area: in men, higher serotonin than testosterone, unbalanced;in women, mood disorders, low prolactin, relationship problems
Symptoms: lack of desire for sex or lack of sexual fantasies; if neither of a couple is distressed, this is not a problem.
Progression:
Causes: in men, low testosterone or high prolactin(precursor to testosterone); no known basis for lifetime lack of interest in sex
Medications: for women: bremelnotide before menopause and flibanserin after menopause.
Therapies: Understanding the culture, some cultures emphasize sexual restraint; others, sexual expression.

Youtube Video: Management of Hypoactive Sexual Desire Among Women

Youtube Video: Male Hypoactive Sexual Disorder

Amazon or Library Book:
Understanding Hypoactive Sexual Desire Disorder

Click the book to link or order from Amazon.

4 CURRENT ARTICLES
FROM PUBMED

The world-wide medical research
reports chosen for each diagnosis 

Clicking each title opens the
PubMed article’s summary-abstract.

  • A multidisciplinary approach to screen the post-COVID-19 conditions
    by Nicola Squillace on January 24, 2023

    CONCLUSIONS: In our sample of patients with severe COVID-19, we found that PCC are highly variable and fluctuating over time; in particular, in about 50% of our patients new SC appear during follow up. Moreover, presence of PCC also in patients without SC at discharge and the variability of symptoms underlining the advisability of our multidisciplinary approach.

  • Chronic liver diseases and erectile dysfunction
    by Guanghui Zang on January 23, 2023

    Chronic liver diseases (CLDs) are characterized by progressive necrosis of hepatocytes, which leads to liver fibrosis and cirrhosis, and ultimately liver dysfunction. The statistics of 2020 shows that the number of patients with CLDs, including chronic hepatitis, fatty liver, and cirrhosis, may exceed 447 million in China. The liver is a crucial organ for the metabolism of various substances, including sex hormones and lipids. CLDs frequently result in abnormalities in the metabolism of sex...

  • Impact of body composition analysis on male sexual function: A metabolic age study
    by Ahmad Majzoub on January 23, 2023

    INTRODUCTION: Metabolic Age (MetAge) and body composition analysis may reflect an individual's metabolic status, which is believed to influence male sexual and gonadal functions. Although erectile dysfunction (ED) and hypogonadism are increasingly prevalent with age, they are also detected among younger men. This study aims to assess the impact of MetAge and body composition on male sexual and gonadal status overall, and particularly in men younger than 40 years of age.

  • Assessment of the Impact of Pentafecta Parameters Affecting the Quality of Life of Patients Undergoing Laparoscopic Radical Prostatectomy
    by Mateusz Wojtarowicz on January 21, 2023

    Prostate cancer is being detected in increasingly younger men. These patients expect to preserve their current quality of life and quickly recover after treatment. Medical technology and surgical techniques are advancing along with the growing expectations of patients. In addition, the universal method of assessing the quality of outcomes after operations is constantly being researched. As of today, biochemical remission alone, after radical prostatectomy, is insufficient for the patient....